Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electronic Schizophrenia Treatment Adherence Registry, eSTAR

NCT00283517 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.

NCT NCT00283517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electronic Schizophrenia Treatment Adherence Registry, eSTAR
Lead sponsor
Janssen-Cilag, S.A.
Phase
Observational
Overall status
Completed
Start date
September 30, 2003
Completion date
May 31, 2006
Enrollment
2,046 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorders, schizophrenia